<p>泰利福公司（NYSE:TFX - 免费报告）- Needham  Company LLC 的股票分析师在 5 月 8 日星期五向投资者发布了对泰利福股票的 2028 年第一季度每股收益预期。Needham  Company LLC 的分析师 M. Matson 预计这家医疗技术公司在该季度的每股收益将为 2.90 美元。Needham  Company LLC 目前对该股票给予 &#34;买入&#34; 评级，目标价为 147.00 美元。市场普遍预期泰利福当前全年的每股收益为 6.75 美元。Needham  Company LLC 还发布了泰利福 2028 财年的每股收益预期为 12.18 美元。</p>
<p>泰利福（NYSE:TFX - 获取免费报告）最近在 5 月 7 日星期四发布了季度财报。这家医疗技术公司报告该季度每股收益为 1.39 美元，超出市场普遍预期的 1.21 美元，超过 0.18 美元。泰利福的净利润率为 -35.88%，股本回报率为 13.29%。该公司该季度的收入为 5.483 亿美元，而市场普遍预期为 5.3691 亿美元。去年同期，该公司的每股收益为 1.44 美元。与去年同期相比，该公司的收入增长了 32.3%。泰利福已将其 2026 财年的指导目标设定为每股收益 6.250-6.550。</p>
<p>其他几位分析师也对该股票发布了报告。富国银行将泰利福的目标价从 130.00 美元上调至 138.00 美元，并在周五的研究报告中给予公司 &#34;持平&#34; 评级。Zacks Research 在 4 月 28 日星期二的研究报告中将泰利福的评级从 &#34;强烈卖出&#34; 上调至 &#34;持有&#34;。Weiss Ratings 在 3 月 27 日星期五的报告中重申了对泰利福的 &#34;卖出（d）&#34; 评级。Raymond James Financial 在周五的研究报告中重申了 &#34;跑赢大盘&#34; 评级，并对泰利福的股票设定了 150.00 美元的目标价。最后，华尔街 Zen 在周六的研究报告中将泰利福的评级从 &#34;持有&#34; 下调至 &#34;卖出&#34;。三位股票研究分析师对该股票给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;持有&#34;，共识目标价为 144.00 美元。</p>
<p><strong>阅读我们对 TFX 的最新分析</strong></p>
<h2>泰利福价格表现</h2>
<p>NYSE:TFX 的股票在星期二开盘价为 129.92 美元。该公司的速动比率为 2.03，流动比率为 2.55，债务与股本比率为 0.82。该股票的市值为 57.5 亿美元，市盈率为 -5.70，市盈增长比率为 0.96，贝塔系数为 0.82。该公司的 50 日移动平均线为 120.08 美元，200 日移动平均线为 116.73 美元。泰利福的 52 周低点为 100.18 美元，52 周高点为 139.67 美元。</p>
<h2>机构投资者对泰利福的看法</h2>
<p>几家机构投资者和对冲基金最近买入和卖出了 TFX 的股票。Empowered Funds LLC 在第一季度将其在泰利福的持股增加了 15.8%。Empowered Funds LLC 目前拥有 1,684 股这家医疗技术公司的股票，价值 233,000 美元，此前在上个季度又增持了 230 股。Jane Street Group LLC 在第一季度将其在泰利福的持股增加了 42.6%。Jane Street Group LLC 目前拥有 6,343 股这家医疗技术公司的股票，价值 877,000 美元，此前在上个季度又增持了 1,895 股。美国世纪公司在第二季度将其在泰利福的持股增加了 32.7%。美国世纪公司目前拥有 13,640 股这家医疗技术公司的股票，价值 1,614,000 美元，此前在上个季度又增持了 3,360 股。Invesco Ltd. 在第二季度将其在泰利福的持股增加了 1.2%。Invesco Ltd. 目前拥有 135,516 股这家医疗技术公司的股票，价值 16,040,000 美元，此前在该期间又购买了 1,659 股。最后，EverSource Wealth Advisors LLC 在第二季度将其在泰利福的持股增加了 108.1%。EverSource Wealth Advisors LLC 目前拥有 1,003 股这家医疗技术公司的股票，价值 119,000 美元，此前在该期间又购买了 521 股。对冲基金和其他机构投资者持有该公司 95.62% 的股票。</p>
<h2>泰利福宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，该分红于 3 月 31 日星期二支付。3 月 6 日星期五的股东获得了每股 0.34 美元的分红。该分红的除息日期为 3 月 6 日星期五。这相当于每年 1.36 美元的分红，收益率为 1.0%。泰利福的分红支付比率目前为 -5.96%。</p>
<h2>影响泰利福的关键头条新闻</h2>
<p>以下是本周影响泰利福的关键新闻：</p>
<ul>
<li>积极情绪：Needham  Company 重申了对泰利福的 <strong>买入</strong> 评级，并设定了 <strong>147</strong> 美元的目标价，同时预测 <strong>2028 财年每股收益为 12.18 美元</strong> 和 <strong>2028 年第一季度每股收益为 2.90 美元</strong>，显示出对长期收益增长的信心。Needham  Company 泰利福估计报告</li>
<li>积极情绪：Citizens JMP 也提高了其收益预期，预测 <strong>2027 财年每股收益为 10.50 美元</strong> 和季度每股收益为 <strong>2.03 美元</strong>、<strong>2.62 美元</strong>、<strong>2.83 美元</strong> 和 <strong>3.05 美元</strong>，这表明分析师们认为未来有显著的利润扩张。Citizens JMP 泰利福估计报告</li>
<li>中性情绪：Truist Financial 重申了 <strong>持有</strong> 评级，但将其目标价从 <strong>135</strong> 美元上调至 <strong>143</strong> 美元，暗示适度的上行空间，但没有强烈的看涨转变。泰利福在 Truist Financial 的持有评级得到重申。</li>
</ul>
<h2>泰利福公司简介</h2>
<p>（获取免费报告）</p>
<p>泰利福公司是一家多元化的全球医疗技术提供商，专注于重症护理和外科手术。公司总部位于宾夕法尼亚州韦恩，设计、制造并分销医疗专业人员在医院、门诊和其他场所使用的设备和解决方案。泰利福致力于提供支持复杂介入程序并改善患者结果的产品。</p>
<p>公司的产品涵盖多个关键领域，包括介入泌尿学、呼吸与麻醉、外科、心脏护理、血管和原始设备制造商（OEM）解决方案。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比泰利福更好</li>
<li>Ubiquiti 的上升趋势可以继续，但不要急于购买</li>
<li>TMC 在海底打造新的电动车供应链</li>
<li>五月卖出，离开——从这三只股票开始</li>
<li>在月球基地建成之前，这四家公司获胜</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在泰利福吗？</h2>
<p>在考虑泰利福之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而泰利福并不在名单上。</p>
<p>虽然泰利福目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

泰利福

<p>泰利福公司（NYSE:TFX）已收到 Needham & Company LLC 对 2028 年第一季度每股收益的预测，预计为 2.90 美元。该公司维持 “买入” 评级，目标价为 147.00 美元。泰利福最近的季度收益为每股 1.39 美元，超出预期。分析师的评级各异，其中三位为买入，五位为持有，一位为卖出。该股开盘价为 129.92 美元，市值为 57.5 亿美元。公司还宣布每股季度分红为 0.34 美元</p>

<p>Teleflex Incorporated (NYSE:TFX - Free Report) - Stock analysts at Needham &amp; Company LLC issued their Q1 2028 earnings per share estimates for shares of Teleflex in a note issued to investors on Friday, May 8th. Needham &amp; Company LLC analyst M. Matson expects that the medical technology company will post earnings per share of $2.90 for the quarter. Needham &amp; Company LLC currently has a &#34;Buy&#34; rating and a $147.00 price target on the stock. The consensus estimate for Teleflex's current full-year earnings is $6.75 per share. Needham &amp; Company LLC also issued estimates for Teleflex's FY2028 earnings at $12.18 EPS.</p>
<div class="lb-trans"><p>泰利福公司（NYSE:TFX - 免费报告）- Needham  Company LLC 的股票分析师在 5 月 8 日星期五向投资者发布了对泰利福股票的 2028 年第一季度每股收益预期。Needham  Company LLC 的分析师 M. Matson 预计这家医疗技术公司在该季度的每股收益将为 2.90 美元。Needham  Company LLC 目前对该股票给予 &#34;买入&#34; 评级，目标价为 147.00 美元。市场普遍预期泰利福当前全年的每股收益为 6.75 美元。Needham  Company LLC 还发布了泰利福 2028 财年的每股收益预期为 12.18 美元。</p>
</div><p>Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. During the same period last year, the firm posted $1.44 earnings per share. The business's revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS.</p>
<div class="lb-trans"><p>泰利福（NYSE:TFX - 获取免费报告）最近在 5 月 7 日星期四发布了季度财报。这家医疗技术公司报告该季度每股收益为 1.39 美元，超出市场普遍预期的 1.21 美元，超过 0.18 美元。泰利福的净利润率为 -35.88%，股本回报率为 13.29%。该公司该季度的收入为 5.483 亿美元，而市场普遍预期为 5.3691 亿美元。去年同期，该公司的每股收益为 1.44 美元。与去年同期相比，该公司的收入增长了 32.3%。泰利福已将其 2026 财年的指导目标设定为每股收益 6.250-6.550。</p>
</div><p>Several other analysts have also issued reports on the stock. Wells Fargo &amp; Company upped their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an &#34;equal weight&#34; rating in a research report on Friday. Zacks Research raised Teleflex from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, April 28th. Weiss Ratings restated a &#34;sell (d)&#34; rating on shares of Teleflex in a report on Friday, March 27th. Raymond James Financial reaffirmed an &#34;outperform&#34; rating and issued a $150.00 price target on shares of Teleflex in a research note on Friday. Finally, Wall Street Zen lowered Teleflex from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and a consensus price target of $144.00.</p>
<div class="lb-trans"><p>其他几位分析师也对该股票发布了报告。富国银行将泰利福的目标价从 130.00 美元上调至 138.00 美元，并在周五的研究报告中给予公司 &#34;持平&#34; 评级。Zacks Research 在 4 月 28 日星期二的研究报告中将泰利福的评级从 &#34;强烈卖出&#34; 上调至 &#34;持有&#34;。Weiss Ratings 在 3 月 27 日星期五的报告中重申了对泰利福的 &#34;卖出（d）&#34; 评级。Raymond James Financial 在周五的研究报告中重申了 &#34;跑赢大盘&#34; 评级，并对泰利福的股票设定了 150.00 美元的目标价。最后，华尔街 Zen 在周六的研究报告中将泰利福的评级从 &#34;持有&#34; 下调至 &#34;卖出&#34;。三位股票研究分析师对该股票给予了买入评级，五位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;持有&#34;，共识目标价为 144.00 美元。</p>
</div><p><strong>Read Our Latest Analysis on TFX</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 TFX 的最新分析</strong></p>
</div><h2>Teleflex Price Performance</h2>
<div class="lb-trans"><h2>泰利福价格表现</h2>
</div><p>Shares of NYSE:TFX opened at $129.92 on Tuesday. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.75 billion, a PE ratio of -5.70, a PEG ratio of 0.96 and a beta of 0.82. The company's fifty day moving average is $120.08 and its 200 day moving average is $116.73. Teleflex has a 52 week low of $100.18 and a 52 week high of $139.67.</p>
<div class="lb-trans"><p>NYSE:TFX 的股票在星期二开盘价为 129.92 美元。该公司的速动比率为 2.03，流动比率为 2.55，债务与股本比率为 0.82。该股票的市值为 57.5 亿美元，市盈率为 -5.70，市盈增长比率为 0.96，贝塔系数为 0.82。该公司的 50 日移动平均线为 120.08 美元，200 日移动平均线为 116.73 美元。泰利福的 52 周低点为 100.18 美元，52 周高点为 139.67 美元。</p>
</div><h2>Institutional Investors Weigh In On Teleflex</h2>
<div class="lb-trans"><h2>机构投资者对泰利福的看法</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of TFX. Empowered Funds LLC raised its holdings in shares of Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company's stock valued at $233,000 after acquiring an additional 230 shares in the last quarter. Jane Street Group LLC boosted its holdings in Teleflex by 42.6% in the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company's stock valued at $877,000 after acquiring an additional 1,895 shares in the last quarter. American Century Companies Inc. boosted its holdings in Teleflex by 32.7% in the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company's stock valued at $1,614,000 after acquiring an additional 3,360 shares in the last quarter. Invesco Ltd. increased its position in Teleflex by 1.2% during the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company's stock valued at $16,040,000 after purchasing an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in Teleflex by 108.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company's stock valued at $119,000 after purchasing an additional 521 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近买入和卖出了 TFX 的股票。Empowered Funds LLC 在第一季度将其在泰利福的持股增加了 15.8%。Empowered Funds LLC 目前拥有 1,684 股这家医疗技术公司的股票，价值 233,000 美元，此前在上个季度又增持了 230 股。Jane Street Group LLC 在第一季度将其在泰利福的持股增加了 42.6%。Jane Street Group LLC 目前拥有 6,343 股这家医疗技术公司的股票，价值 877,000 美元，此前在上个季度又增持了 1,895 股。美国世纪公司在第二季度将其在泰利福的持股增加了 32.7%。美国世纪公司目前拥有 13,640 股这家医疗技术公司的股票，价值 1,614,000 美元，此前在上个季度又增持了 3,360 股。Invesco Ltd. 在第二季度将其在泰利福的持股增加了 1.2%。Invesco Ltd. 目前拥有 135,516 股这家医疗技术公司的股票，价值 16,040,000 美元，此前在该期间又购买了 1,659 股。最后，EverSource Wealth Advisors LLC 在第二季度将其在泰利福的持股增加了 108.1%。EverSource Wealth Advisors LLC 目前拥有 1,003 股这家医疗技术公司的股票，价值 119,000 美元，此前在该期间又购买了 521 股。对冲基金和其他机构投资者持有该公司 95.62% 的股票。</p>
</div><h2>Teleflex Announces Dividend</h2>
<div class="lb-trans"><h2>泰利福宣布分红</h2>
</div><p>The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex's dividend payout ratio is presently -5.96%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，该分红于 3 月 31 日星期二支付。3 月 6 日星期五的股东获得了每股 0.34 美元的分红。该分红的除息日期为 3 月 6 日星期五。这相当于每年 1.36 美元的分红，收益率为 1.0%。泰利福的分红支付比率目前为 -5.96%。</p>
</div><h2>Key Headlines Impacting Teleflex</h2>
<div class="lb-trans"><h2>影响泰利福的关键头条新闻</h2>
</div><p>Here are the key news stories impacting Teleflex this week:</p>
<div class="lb-trans"><p>以下是本周影响泰利福的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Needham &amp; Company reiterated a <strong>Buy</strong> rating on Teleflex and set a <strong>$147</strong> price target, while projecting <strong>FY2028 EPS of $12.18</strong> and <strong>Q1 2028 EPS of $2.90</strong>, signaling confidence in longer-term earnings growth. Needham &amp; Company Teleflex estimate report</li>
<li>Positive Sentiment: Citizens JMP also raised its earnings expectations, forecasting <strong>FY2027 EPS of $10.50</strong> and quarterly EPS of <strong>$2.03</strong>, <strong>$2.62</strong>, <strong>$2.83</strong>, and <strong>$3.05</strong> for 2027, which suggests analysts see meaningful profit expansion ahead. Citizens JMP Teleflex estimate report</li>
<li>Neutral Sentiment: Truist Financial reaffirmed a <strong>Hold</strong> rating but lifted its price target to <strong>$143</strong> from <strong>$135</strong>, implying moderate upside without a strong bullish shift. Teleflex Hold rating reaffirmed at Truist Financial</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Needham  Company 重申了对泰利福的 <strong>买入</strong> 评级，并设定了 <strong>147</strong> 美元的目标价，同时预测 <strong>2028 财年每股收益为 12.18 美元</strong> 和 <strong>2028 年第一季度每股收益为 2.90 美元</strong>，显示出对长期收益增长的信心。Needham  Company 泰利福估计报告</li>
<li>积极情绪：Citizens JMP 也提高了其收益预期，预测 <strong>2027 财年每股收益为 10.50 美元</strong> 和季度每股收益为 <strong>2.03 美元</strong>、<strong>2.62 美元</strong>、<strong>2.83 美元</strong> 和 <strong>3.05 美元</strong>，这表明分析师们认为未来有显著的利润扩张。Citizens JMP 泰利福估计报告</li>
<li>中性情绪：Truist Financial 重申了 <strong>持有</strong> 评级，但将其目标价从 <strong>135</strong> 美元上调至 <strong>143</strong> 美元，暗示适度的上行空间，但没有强烈的看涨转变。泰利福在 Truist Financial 的持有评级得到重申。</li>
</ul>
</div><h2>Teleflex Company Profile</h2>
<div class="lb-trans"><h2>泰利福公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.</p>
<div class="lb-trans"><p>泰利福公司是一家多元化的全球医疗技术提供商，专注于重症护理和外科手术。公司总部位于宾夕法尼亚州韦恩，设计、制造并分销医疗专业人员在医院、门诊和其他场所使用的设备和解决方案。泰利福致力于提供支持复杂介入程序并改善患者结果的产品。</p>
</div><p>The company's offerings span several key segments, including Interventional Urology, Respiratory &amp; Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.</p>
<div class="lb-trans"><p>公司的产品涵盖多个关键领域，包括介入泌尿学、呼吸与麻醉、外科、心脏护理、血管和原始设备制造商（OEM）解决方案。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Teleflex</li>
<li>Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It</li>
<li>TMC Forges a New EV Supply Chain at the Bottom of the Sea</li>
<li>Sell in May and Go Away—Starting With These 3 Stocks</li>
<li>Before the Moon Base Gets Built, These 4 Companies Win</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比泰利福更好</li>
<li>Ubiquiti 的上升趋势可以继续，但不要急于购买</li>
<li>TMC 在海底打造新的电动车供应链</li>
<li>五月卖出，离开——从这三只股票开始</li>
<li>在月球基地建成之前，这四家公司获胜</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRGWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=TFX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Teleflex Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在泰利福吗？</h2>
</div><p>Before you consider Teleflex, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑泰利福之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而泰利福并不在名单上。</p>
</div><p>While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然泰利福目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

研究分析师发布了泰利福第一季度收益预测